I think that last point reiterates what I said earlier. The device is HIGHLY unlikely to be doing any harm or reducing the effectiveness of treatments. So of course IVF units will be "delighted to participate" if there is potential that the device will be able to reduce time and costs. Don't forget, the majority of large IVF clinics around the world these days are owned by corporates, the way they view things is very different to the old days when Professors and public hospitals owned the units.
We've seen with the VRT and MVF share price that growth in this sector is becoming harder and harder to achieve, so the only two things the companies can do is 1) acquisitions (which is difficult) and 2) reduce costs.
